Cancer BiologybioRxivPreprint
Integrated genetic screening reveals FEN1 as a driver of stemness and temozolomide resistance in glioblastoma
Benjamin A. Brakel, Dillon McKenna, Anish Puri…·Sheila Kumari Singh
This study identifies FEN1 as a driver of glioblastoma stem cell survival and temozolomide resistance, showing FEN1 inhibition can enhance TMZ efficacy in aggressive tumors.
DOI 10.1101/2025.06.18.660339